US 2026/0090984 A1 · CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS

Abstract

The present invention recognizes that medical devices, such as contact lenses, can be made having at least one coating layer provide drug storage and drug release for the treatment of various diseases, disorders, or conditions. One aspect includes a packaged medical device including a medicament. Another aspect includes a drug delivery contact lens. A further aspect includes a method of making a drug delivery contact lens. An additional aspect includes a method of using a drug delivery contact lens. A further aspect includes a medical device including bimatoprost and N-vinylpyrrolidone. An additional aspect includes a contact lens soaking solution. Another aspect includes a method of loading contact lenses. Another aspect includes loaded and refreshed contact lenses. A further aspect includes methods of using loaded and refreshed contact lenses.

Claims142

Dependent claims

A packaged medical device, comprising:

a) at least one drug delivery contact lens, comprising:
1) at least one coating provided on at least one surface of said drug delivery contact lens;
a) wherein said at least one coating comprises at least one polymerized PEG monomer;
b) further wherein said at least one coating comprises at least one drug;
b) at least one packaging solution, comprising:
1) at least one of said at least one drug;
c) at least one packaging, comprising:
1) said at least one drug delivery contact lens;
and
2) said at least one packaging solution.

7 more elements

Dependencies are inferred from the claim text.

Facts

Application

19/411,056Filed 5 Dec 2025

Priority

6 Jun 2023

Published

2 Apr 2026

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

G11C 29/46
Built-in arrangements for testing, e.g. built-in self testing [BIST] or interconnection details: test trigger logic
A61K 9/0051
Eye, e.g. artificial tears: ocular inserts or implants
A61K 31/46
Having six-membered rings with one nitrogen as the only ring hetero atom: 8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
A61K 31/5575
Eicosanoids, e.g. leukotrienes or prostaglandins: having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha

Contact lenses including medicaments and methods of making and using same including slow release of glaucoma treating drugs and comfort enhancing drugs

Life of this patent

Contact lenses including medicaments and methods of making and using same including slow release of glaucoma treating drugs and comfort enhancing drugs

Life of this patent

Abstract

Claims142